Market Performance
Becton, Dickinson and Company (NYSE:BDX) reached a new 52-week high of $213.52 during today's trading session.
The Healthcare stock has traded year-to-date and 2.1% over the past week. The previous 52-week high was $213.08.
52 week highNYSE:BDX
Becton, Dickinson and Company (BDX) Hits New 52-Week High of $213.52
Becton, Dickinson and Company (NYSE:BDX) reached a new 52-week high of $213.52 during today's trading session.
At publication ·
What changed
Becton, Dickinson and Company (NYSE:BDX) · 52 week high
- Price at event
- $213.52
- Price change
- 2.07%
- Average volume to event volume
- 2M to 3.1M
- 52-week high
- $213.08
- 52-week low
- $140.11
At a glance
Key takeaways
- Becton, Dickinson and Company (BDX) reached a new 52-week high of $213.52, up 2.1% over the past week.
Company Overview
Becton, Dickinson and Company has a market capitalization of $57.4B. The stock's 52-week low was $140.11.
Reaching a 52-week high often signals strong momentum and investor confidence in Becton, Dickinson and Company. Stocks at new highs can continue trending higher as breakout buying kicks in, though they also face increased selling pressure from profit-taking. The key question is whether fundamentals support the elevated valuation.
Becton, Dickinson and Company currently trades at $213.52, positioning the stock at the 100th percentile of its 52-week range ($140.11 — $213.08). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View BDX Stock Page
Frequently Asked Questions
What is causing BDX's price movement?
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our BDX news page.
What is BDX's 52-week range?
See full price history and interactive charts on our BDX chart page.
